title: Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: A placebo controlled trial.
abstract: The purpose of this study was to evaluate the effect of memantine administration on the adverse cognitive effects of electroconvulsive therapy (ECT). Forty patients diagnosed with a major depressive disorder for which ECT was indicated as a treatment for their current episode were randomly allocated to either the memantine (5mg/day) group or the placebo group. All patients underwent the same protocol for anaesthesia and ECT procedures. The patients received memantine or the placebo for the whole period of ECT treatment, starting the day before ECT and continuing until the fourth session of ECT. The Modified Mental State Examination (MMSE) was used for the assessment of cognition before and after the trial. Regarding MMSE and item 3 MMSE (related to recent memory), the memantine group scored significantly higher at the end of ECT sessions than the control group (P=0.02, P<0.001, respectively). Our data support the hypothesis that memantine may reduce cognitive impairment following ECT. Memantine could be both a safe and well-tolerated treatment for use with ECT.
authors.affiliation: Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: m_abbasi@sbmu.ac.ir.
authors.forename: Mohammad
authors.initials: M
authors.lastname: Abbasinazari
authors.affiliation: Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
authors.forename: Ladan
authors.initials: L
authors.lastname: Adib-Eshgh
authors.affiliation: Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
authors.forename: Azin
authors.initials: A
authors.lastname: Rostami
authors.affiliation: Department of Psychiatry, Taleghani Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran.
authors.forename: Narges
authors.initials: N
authors.lastname: Beyraghi
authors.affiliation: Department of Anesthesiology, Akhtar Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
authors.forename: Shideh
authors.initials: S
authors.lastname: Dabir
authors.affiliation: Student Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: Reyhaneh
authors.initials: R
authors.lastname: Jafari
mesh_terms: D000328:Adult; D003072:Cognition Disorders / Q000209:etiology* / Q000517:prevention & control; D003865:Major Depressive Disorder / Q000628:therapy; D004311:Double-Blind Method; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008559:Memantine / Q000009:adverse effects / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009483:Neuropsychological Tests
chemical_list: D018696:Neuroprotective Agents; D008559:Memantine
keywords: Cognition; Electroconvulsive therapy; Memantine; Modified Mental State Examination